percentage of people on glp 1 33% adults with type 2 diabetes lost 5% or more of body weight with GLP-1 agonists KFF Health Tracking Poll May

[DOI] [PubMed] [Google Scholar] 87.Ochiai M., Hayashi T., Morita M., Ina K., Maeda M., Watanabe F., Morishita K

Compound: Micronized PEA 200mg(Palmitoylethanolamide)

Notably, although there was not a statistically significant increase in biliary disease among GLP-1 receptor agonist users in this study, the FDA 2 added warnings and precautions about acute cholecystitis and biliary disease to the label in late 2022 based on data from placebo-controlled RCTs as well as other observational data 3

If retatrutide is used regardless of this risk, patients require explicit information on what symptoms to monitor for and when to seek assistance

For decreased appetite, choose nutrient-dense foods in smaller portions and report rapid weight loss to your doctor

A., Iliev, I